Skip to main content
Department of Pathology

Research

The main interest of research in our department is the application of recent pathological research methodologies to understand the pathogenesis, improve the diagnosis and predict the prognosis of human disease.

The department collaborates with other clinical departments in different research fields and theses. It also provides research opportunities for postgraduates and staff from the department and from any other discipline both from Egypt and abroad.

The main research facilities available at the department:

  1. Histopathological examination and evaluation of tissues .
  2. Cytopathological assessment of exfoliative and FNA cytology.
  3. immunohistochemical – based researches.

         Research Plan

# Title Research Year
401 High concentrations of retinoids induce differentiation and late apoptosis in pancreatic cancer cells in vitro 2005
402 The relationships between p53 protein expression and the clinicopathological features in the uveal melanomas, 2005
403 Analysis of the Bcl-2 and p53 protein expression in the lymphoproliferative lesions in the upper Egypt 2005
404 Analysis of fibronectin expression in the bilharzial granulomas and of laminin in the transformed urothelium in schistosoma haematobium infested patients 2005
405 Ultrastructural evaluation of the radioprotective effects of melatonin against X-ray-induced skin damage in Albino rats, 2005
406 Analysis of Bcl-2 and p53 protein expression in non-Hodgkin's lymphoma 2004
407 Alterations of p53, Bcl-2, and hMSH2 protein expression in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas in the upper Egypt 2004
408 Alterations of p53, Bcl-2, and hMSH2 protein expression in the normal breast, benign proliferative breast disease, in situ and infiltrating ductal breast carcinomas in the upper Egypt 2004
409 Genetic pathways to melanoma tumorigenesis, 2004
410 Analysis of p53 and bcl-2 protein expression in the non-tumorigenic, pretumorigenic, and tumorigenic keratinocytic hyperproliferative lesions, 2004